Form 8-K - Current report:
SEC Accession No. 0000950170-24-101395
Filing Date
2024-08-28
Accepted
2024-08-28 16:10:30
Documents
11
Period of Report
2024-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K krro-20240826.htm   iXBRL 8-K 49172
  Complete submission text file 0000950170-24-101395.txt   211182

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krro-20240826.xsd EX-101.SCH 54301
14 EXTRACTED XBRL INSTANCE DOCUMENT krro-20240826_htm.xml XML 6718
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 241255524
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)